Zhi-Heng Chen, et al. “Serological Thymidine Kinase1 Is a Biomarker for Early Risk of Tumours Progression —Real World Data from a Health Screening Study on a Cohort of 35,365 People”. Newest Updates in Physical Science Research Vol. 5, May 2021, pp. 36-65, doi:10.9734/bpi/nupsr/v5/1960F.